Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Purified recombinant fragment of human NFKBIB expressed in E. Coli.|
|Contains||0.03% sodium azide|
|Storage Conditions||Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.|
|Tested Applications||Dilution *|
|Western Blot (WB)||1/500 - 1/2000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
MA5-15673 targets NFKBIB in WB applications and shows reactivity with Human samples.
The MA5-15673 immunogen is purified recombinant fragment of human NFKBIB expressed in E. Coli.
MA5-15673 detects NFKBIB which has a predicted molecular weight of approximately 45kDa.
NFKB1 or NFKB2 is bound to REL to form the NFKB complex. The NFKB complex is inhibited by I-kappa-B proteins marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NF-kappa-B complex. Activated NFKB complex translocates into the nucleus and binds DNA at kappa-B-binding motifs such as 5-prime GGGRNNYYCC 3-prime or 5-prime HGGARNYYCC 3-prime .
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
I-kappa-B-beta; ikappaBbeta; ikB-B; ikB-beta; IKBB; NF-kappa-BIB; NFKBIB; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; thyroid receptor-interacting protein 9; TR-interacting protein 9; TRIP-9; TRIP9
IKBB; NFKBIB; TRIP9